Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study

J. Langhorst; I. Varnhagen; S. B. Schneider; U. Albrecht; A. Rueffer; R. Stange; A. Michalsen; G. J. Dobos

doi:10.1111/apt.12397

journal article Jul 04, 2013

Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study

J. Langhorst I. Varnhagen S. B. Schneider U. Albrecht A. Rueffer R. Stange A. Michalsen G. J. Dobos

Alimentary Pharmacology & Therapeutics Vol. 38 No. 5 pp. 490-500 · Wiley

View at Publisher Save 10.1111/apt.12397

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Dignass "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: current management" J Crohns Colitis (2012) 10.1016/j.crohns.2012.09.002

[2]

Dignass "Update German guideline on diagnosis and treatment of ulcerative colitis" Z Gastroenterol (2011) 10.1055/s-0031-1281666

[3]

Gisbert "5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review" Inflamm Bowel Dis (2007) 10.1002/ibd.20099

[4]

Allgayer "Sulfasalazine and 5-ASA compounds" Gastroenterol Clin North Am (1992) 10.1016/s0889-8553(21)00053-4

[5]

Das "Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype" N Engl J Med (1973) 10.1056/nejm197309062891001

[6]

Barnes (2008)

[7]

Callahan "Use of complementary and alternative medicine among patients with arthritis" Prev Chronic Dis (2009)

[8]

Shaw "Predictors of complementary therapy use among asthma patients: results of a primary care survey" Health Soc Care Community (2008) 10.1111/j.1365-2524.2007.00738.x

[9]

Ferrucci "Complementary and alternative medicine use in chronic liver disease patients" J Clin Gastroenterol (2010) 10.1097/mcg.0b013e3181b766ed

[10]

Hilsden "Complementary medicine use by patients with inflammatory bowel disease" Am J Gastroenterol (1998) 10.1111/j.1572-0241.1998.208_a.x

[11]

Hilsden "Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey" Am J Gastroenterol (2003) 10.1111/j.1572-0241.2003.07519.x

[12]

Langhorst "Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey" Inflamm Bowel Dis (2005) 10.1097/01.mib.0000160771.71328.6c

[13]

Langhorst "Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use" Complement Ther Med (2007) 10.1016/j.ctim.2006.03.008

[14]

Hilsden "Use of complementary and alternative medicine by patients with inflammatory bowel disease" Inflamm Bowel Dis (2011) 10.1002/ibd.21360

[15]

Weizman "Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease" Aliment Pharmacol Ther (2012) 10.1111/j.1365-2036.2011.04956.x

[16]

Rahimi "On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies" Dig Dis Sci (2009) 10.1007/s10620-008-0368-x

[17]

Langmead "Use of complementary therapies by patients with IBD may indicate psychosocial distress" Inflamm Bowel Dis (2002) 10.1097/00054725-200205000-00003

[18]

Ganguli "Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?" Am J Gastroenterol (2004) 10.1111/j.1572-0241.2004.04046.x

[19]

Myrrhinil intest - Fachinformation Rote Liste Servive GmbH, Fachinfo-Service 2009 1

[20]

Tariq "Anti-inflammatory activity of Commiphora molmol" Agents Actions (1985)

[21]

Zhu "Isolation and characterization of several aromatic sesquiterpenes from commiphora myrrha" Flavour Fragr J (2003) 10.1002/ffj.1193

[22]

Dolara "Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh" Planta Med (2000) 10.1055/s-2000-8532

[23]

al-Harbi "Anticarcinogenic effect of Commiphora molmol on solid tumors induced by Ehrlich carcinoma cells in mice" Chemotherapy (1994) 10.1159/000239216

[24]

Qureshi "Evaluation of the genotoxic, cytotoxic, and antitumor properties of Commiphora molmol using normal and Ehrlich ascites carcinoma cell-bearing Swiss albino mice" Cancer Chemother Pharmacol (1993) 10.1007/bf00685330

[25]

Isaac "Pharmacological investigations with compounds of chamomile i. on the pharmacology of (-)-alpha-bisabolol and bisabolol oxides (review) (author's transl)" Planta Med (1979) 10.1055/s-0028-1097193

[26]

Jakovlev "Pharmacological investigations with compounds of chamomile ii. new investigations on the antiphlogistic effects of (-)-alpha-bisabolol and bisabolol oxides (author's transl)" Planta Med (1979) 10.1055/s-0028-1097194

[27]

Achterrath-Tuckermann "Untersuchungen über die spasmolytische Wirkung von Kamilleninhaltsstoffen und von Kamillosan am isolierten Meerschweinchenherzen" Planta Med (1980) 10.1055/s-2008-1074901

[28]

Della Loggia "Lokale antiphlogistische Wirkung der Kamillen-Flavone" Dtsch Apoth-Ztg (1985)

[29]

Della Loggia "Evaluation of anti-inflammatory activity of chamomile preparations" Planta Med (1990) 10.1055/s-2006-961313

[30]

Ammon "Pharmakologie der Kamille und ihrer Inhaltsstoffe" Dtsch. Apoth. Ztg. Suppl. (1992)

[31]

Safayhi "Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation" Planta Med (1994) 10.1055/s-2006-959520

[32]

Jänicke (2003)

[33]

Kuhn "Experimentelle Beiträge zur Chemie der Heislerschen “Kaffeekohle”" Südd Apoth-Ztg (1939)

[34]

Rachmilewitz "On behalf of an international study group. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial" BMJ (1989) 10.1136/bmj.298.6666.82

[35]

Langhorst "Non-invasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin and PMN-elastase, CRP, and clinical indices" Am J Gastroenterol (2008) 10.1111/j.1572-0241.2007.01556.x

[36]

Dave "Mucosal healing in inflammatory bowel disease-a true paradigm of success?" Gastroenterol Hepatol (NY) (2012)

[37]

Langhorst "Fecal lactoferrin as non-invasive biomarker in inflammatory bowel disease" Drugs Today (2012) 10.1358/dot.2012.48.2.1732555

[38]

Ford "Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis" Am J Gastroenterol (2011) 10.1038/ajg.2011.67

[39]

Kao "Inducing and maintaining remission in ulcerative colitis role of high-dose, extended-release mesalamine" J Clin Gastroenterol (2010) 10.1097/mcg.0b013e3181db1a61

[40]

Sutherland "Alternatives to sulfasalazine: a metaanalysis of 5-ASA in the treatment of ulcerative colitis" Inflamm Bowel Dis (1997) 10.1097/00054725-199706000-00001

Cited By

87

Investigation effect of oral chamomilla on sleep quality in elderly people in Isfahan: A randomized control trial

Mehrdad Abdullahzadeh, Pegah Matourypour · 2017

Journal of Education and Health Pro...

The Effect of Matricaria Chamomilla on Sleep Quality of Elderly People Admitted to Nursing Homes

M Abdullahzadeh, SA Naji · 2014

Iran Journal of Nursing

Metrics

87

Citations

40

References

Details

Published: Jul 04, 2013
Vol/Issue: 38(5)
Pages: 490-500
License: View

Authors

J

J. Langhorst

Department for Integrative Gastroenterology; Kliniken Essen-Mitte; University of Duisburg-Essen; Essen Germany; Department for Internal and Integrative Medicine; Kliniken Essen-Mitte; University of Duisburg-Essen; Essen Germany

I

I. Varnhagen

Department for Integrative Gastroenterology; Kliniken Essen-Mitte; University of Duisburg-Essen; Essen Germany

S

S. B. Schneider

Biometric Institute; University of Hannover; Hannover Germany

U

U. Albrecht

Mediconomics GmbH; Hannover Germany

A

A. Rueffer

Enterosan; Labor L+S; Bad Bocklet - Grossenbrach Germany

R

R. Stange

Immanuel Hospital; Charité University Medical Center; Berlin Germany

A

A. Michalsen

Immanuel Hospital; Charité University Medical Center; Berlin Germany

G

G. J. Dobos

Department for Internal and Integrative Medicine; Kliniken Essen-Mitte; University of Duisburg-Essen; Essen Germany

Cite This Article

J. Langhorst, I. Varnhagen, S. B. Schneider, et al. (2013). Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study. Alimentary Pharmacology & Therapeutics, 38(5), 490-500. https://doi.org/10.1111/apt.12397

Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis - a double-blind, double-dummy study

You May Also Like